[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356597-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356597-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-role-of-radiomics-in-predicting-the-response-to-neoadjuvant-chemotherapy-for-breast-cancer-review","The role of radiomics in predicting the response to neoadjuvant chemotherapy for breast cancer - Review","","Breast cancer exhibits profound biological and spatial heterogeneity, contributing to variable responses to neoadjuvant chemotherapy (NAC) and complicating precision treatment planning. Radiomics converts standard medical images into high-dimensional quantitative data, enabling non-invasive capture of tumor phenotype, heterogeneity, and treatment-induced changes. This review summarizes recent radiomics advances for breast cancer NAC, focusing on predicting pathologic complete response (pCR), monitoring early efficacy, and quantifying intratumoral heterogeneity, including MRI-based, longitudinal, delta, and multi-omics integration. Key limitations include methodological variability and insufficient external validation, while future directions emphasize harmonized protocols, explainable AI, and prospective multicenter trials.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-role-of-radiomics-in-predicting-the-response-to-neoadjuvant-chemotherapy-for-breast-cancer-review/356597/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-role-of-radiomics-in-predicting-the-response-to-neoadjuvant-chemotherapy-for-breast-cancer-review/356597.png","ImageObject",300,407,{"name":42,"@type":43},"WPS_1786070896","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-16","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does radiomics help predict the response to neoadjuvant chemotherapy in breast cancer?","Question",{"text":63,"@type":64},"Radiomics converts routine medical images into quantitative features that characterize tumor phenotype and heterogeneity, enabling prediction of pathologic complete response (pCR) and treatment response patterns.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which MRI-based radiomics approaches show strong performance for pCR prediction?",{"text":68,"@type":64},"MRI-based radiomics using dynamic contrast-enhanced and diffusion-weighted sequences demonstrates robust predictive performance, including multi-center results reporting AUC values greater than 0.80.",{"name":70,"@type":61,"acceptedAnswer":71},"What are the main barriers to widespread clinical adoption of radiomics?",{"text":72,"@type":64},"Clinical adoption is limited by methodological variability, lack of standardization, and insufficient external validation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356597,1790144869,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":118,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":104,"preview_page_count":26,"preview_urls":145},549768072016,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Cancer Biol Med 2026. doi: 10.20892/j.issn.2095-3941.2025.0655  \nREVIEW  \nThe role of radiomics in predicting the response toneoadjuvant chemotherapy for breast cancer  \nYilin Chen 1, Ye Qin 1, Man Yang2, Wei Li3, Minyi Cheng 1, Yuhong Huang 1, Teng Zhu 1, Kun Wang 1,2  \n1 Department of Breast Cancer, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China; 2The Second School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China; 3 Department of Breast Cancer, The First People’s Hospital of Foshan, Foshan 528000, China  \n\n| ABSTRACT | Breast cancer exhibits profound biological and spatial heterogeneity, which contributes to variable responses to neoadjuvant chemotherapy (NAC) and challenges precision treatment planning. Radiomics, an emerging discipline that converts standard medical images into high-dimensional quantitative data, offers a non-invasive and reproducible means to capture tumor phenotype, heterogeneity, and treatment-induced changes. This review provides a comprehensive overview of recent advances in radiomics for breast cancer NAC, emphasizing the roles in predicting a pathologic complete response (pCR), monitoring early therapeutic efficacy, and quantifying intratumoral heterogeneity. Among imaging modalities, magnetic resonance imaging (MRI)-based radiomics, particularly utilizing dynamic contrast-enhanced and diffusion-weighted sequences, demonstrates robust predictive performance for the pCR, with multi-center studies reporting area under the curve (AUC) values >0.80 . Longitudinal and delta-radiomics approaches further enhance early response evaluation by tracking temporal alterations in imaging features that precede measurable morphologic regression. Radiomic assessment of tumor heterogeneity, especially in triple-negative breast cancer (TNBC), reveals strong associations with immune infiltration, metabolic reprogramming, and therapeutic resistance, providing mechanistic insight into radiomic biomarkers. Integrative multi-omics frameworks, combining radiomics with genomics, transcriptomics and pathomics, are increasingly elucidating the biological underpinnings of imaging phenotypes, improving both model interpretability and clinical relevance. Despite these advances, widespread clinical adoption of radiomics is limited by methodologic variability, lack of standardization, and insufficient external validation. Future efforts should focus on harmonized imaging protocols, explainable artificial intelligence, and prospective multi-center trials to translate radiomics into a clinically actionable tool. Collectively, radiomics represents a transformative approach for individualized response prediction and dynamic treatment optimization in precision breast cancer management (Figure 1) . |\n| --- | --- |\n| KEYWORDS | Breast cancer; radiomics; neoadjuvant chemotherapy; deep learning; pathologic complete response |\n\nIntroduction  \nClinical and biological background of breast cancer and NAC  \nBreast cancer remains one of the leading causes of cancer-related mortality among women worldwide owing to the  \nCorrespondence to: Yuhong Huang, Teng Zhu and Kun Wang  \nE-mail: [huangyuhong@gdph.org.cn](huangyuhong@gdph.org.cn), [zhuteng@gdph.org.cn](zhuteng@gdph.org.cn) and  \n[wangkun@gdph.org.cn](wangkun@gdph.org.cn)  \nORCID ID: [https://orcid.org/0000-0002-1711-8393](https://orcid.org/0000-0002-1711-8393), [https://](https://)[ ](https://)[orcid.org/0000-0003-3036-3446](orcid.org/0000-0003-3036-3446) and [https://orcid](https://orcid).  \norg/0000-0001-9851-7080  \nReceived November 4, 2025; accepted March 11, 2026. Available [at www.cancerbiomed.org](at www.cancerbiomed.org)  \n©2026 The Authors. Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4 .0)  \ndistinct epidemiologic patterns and profound biological heterogeneity1-3. Such heterogeneity contributes to heterogeneous responses to systemic therapi","cbCaifPNS1OW9IRa","https://ap.wps.com/l/cbCaifPNS1OW9IRa","pdf",1189284,"English","# Introduction\n## Clinical and biological background of breast cancer and NAC\n# Radiomics workflow and applications\n## Predicting pCR\n## Early efficacy assessment\n## Quantifying tumor heterogeneity\n## Multi-omics integration\n# Challenges and future directions\n## Generalizability and multicenter validation\n## Standardization and interpretability\n## Clinical translation and prospective trials","[{\"question\":\"How does radiomics help predict the response to neoadjuvant chemotherapy in breast cancer?\",\"answer\":\"Radiomics converts routine medical images into quantitative features that characterize tumor phenotype and heterogeneity, enabling prediction of pathologic complete response (pCR) and treatment response patterns.\"},{\"question\":\"Which MRI-based radiomics approaches show strong performance for pCR prediction?\",\"answer\":\"MRI-based radiomics using dynamic contrast-enhanced and diffusion-weighted sequences demonstrates robust predictive performance, including multi-center results reporting AUC values greater than 0.80.\"},{\"question\":\"What are the main barriers to widespread clinical adoption of radiomics?\",\"answer\":\"Clinical adoption is limited by methodological variability, lack of standardization, and insufficient external validation.\"}]","The role of radiomics in predicting the response to neoadjuvant chemotherapy for breast cancer - Review | PDF",1790126131,[146,150],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/45e2421c265feb941506fc579b734b38.webp",983,1287,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/b958bd6094370654661cb83baa5cdee2.webp",982,1286]